Detalles de la búsqueda
1.
Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial.
Lancet Reg Health Eur
; 28: 100613, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37131861
Resultados
1 -
1
de 1
1
Próxima >
>>